Journal article
Effect of candesartan on New York Heart Association functional class
Abstract
AIMS: To evaluate the effect of the angiotensin receptor blocker candesartan on New York Heart Association (NYHA) functional class in a broad spectrum of patients with chronic heart failure (CHF).
METHODS AND RESULTS: Patients in the CHARM Programme with symptomatic CHF were randomized to placebo (n=3796) or candesartan (n=3803) and followed for a median of 38 months. NYHA class was assessed at baseline, at two weekly intervals during dose …
Authors
O'Meara E; Solomon S; McMurray J; Pfeffer M; Yusuf S; Michelson E; Granger C; Olofsson B; Young JB; Swedberg K
Journal
European Heart Journal, Vol. 25, No. 21, pp. 1920–1926
Publisher
Oxford University Press (OUP)
Publication Date
November 2004
DOI
10.1016/j.ehj.2004.07.025
ISSN
0195-668X